Lv5
840 积分 2021-10-04 加入
Exploring biological heterogeneity and implications on novel treatment paradigm in BRAF-mutant metastatic colorectal cancer
1天前
待确认
Recent developments in immunotherapy for gastrointestinal tract cancers
2天前
已完结
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
2天前
已完结
A triple threat in colorectal cancer
2天前
已完结
Regorafenib, Ipilimumab, and Nivolumab for Patients With Microsatellite Stable Colorectal Cancer and Disease Progression With Prior Chemotherapy
2天前
已完结
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
2天前
已完结
PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy
2天前
已完结
Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside
2天前
已完结
Cancer immune evasion, immunoediting and intratumour heterogeneity
6天前
已完结
A guide to cancer immunotherapy: from T cell basic science to clinical practice
6天前
已完结
皖公网安备34019202002308
